[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569721":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":23,"responsibleParty":43,"collaborators":45,"id":48,"slug":10,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":49,"sex":55,"minAge":56,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":10,"overallStatus":26,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Kerecis Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Thor closure patients",null,"Patients who achieved closure in during the THOR clinical trial",[13,19],{"name":14,"role":15,"phone":16,"phoneExt":17,"email":18},"Bennett Rogers","CONTACT","888-960-1343","1008","brogers@serenagroups.com",{"name":20,"role":15,"phone":21,"phoneExt":10,"email":22},"Thomas Serena, MD","814-688-4000","tserena@serenagroups.com",[24],{"facility":25,"status":26,"city":27,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Serena Group","RECRUITING","Monroeville","Pennsylvania","15146","United States","US",{"type":33,"coordinates":34},"Point",[35,36],-79.7881,40.42118,{"lat":36,"lon":35},[39],{"name":40,"role":15,"phone":41,"phoneExt":10,"email":42},"Laura Serena","412-212-0123","lserena@serenagorups.com",{"type":44,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[46],{"name":25,"class":47},"OTHER","100569721",false,"NCT06697925","Evaluating the Durability of Closure for Venous Leg Ulcers","Prospective Multicenter Observational Study Evaluating the Durability of Closure for Venous Leg Ulcers Following a Randomized, Controlled, Clinical Trial","THORSDOTTIR","Inclusion Criteria:\n\n* 1\\. Subjects must have participated in the THOR trial and achieved complete closure by the 12-week endpoint.\n\nExclusion Criteria:\n\n* 1\\. Subjects who did not participate in the THOR trial. 2. Subjects who participated in the THOR trial and did not achieve complete closure.","ALL","18 Years",{"count":58,"type":59},150,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to determine the durability of closure for venous leg ulcer subjects that achieved closure in the THOR trial.",[63,64,65,66,67],"Venous Leg","Venous Leg Ulcer (VLU)","Venous Leg Ulcer","Venous Ulcer","VLU","2025-01-22",{"date":70,"type":71},"2025-01-24","ACTUAL",{"date":73,"type":59},"2025-01",{"date":75,"type":59},"2026-12",{"name":5,"class":6},1]